Marshall Wace
FBIO icon

Marshall Wace’s Fortress Biotech FBIO Stock Holding History

Marshall Wace’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,716
Closed -$95K – 3553
2022
Q1 		$95K Buy
4,716
+3,906
+482% +$107K ﹤0.01% 3201
2021
Q4 		$30K Buy
+810
New +$36.1K ﹤0.01% 3657
2020
Q1 		– Sell
-1,480
Closed -$57K – 1763
2019
Q4 		$57K Sell
1,480
-1,574
-52% -$40.4K ﹤0.01% 1532
2019
Q3 		$65K Buy
+3,054
New +$71.8K ﹤0.01% 1444

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Marshall Wace's FBIO Position: Q2 2022 in Review

Marshall Wace sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 4,716 shares — an estimated $95K sold.

Marshall Wace first reported a position in FBIO in Q3 2019 and held it in 4 quarters. The position peaked at $95K in Q1 2022. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Marshall Wace reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Marshall Wace sold 4,716 Fortress Biotech shares in Q2 2022, an estimated $95K.
  • Marshall Wace first reported a position in Fortress Biotech in Q3 2019 and held it in 4 quarters.
  • Marshall Wace's Fortress Biotech position peaked at $95K in Q1 2022.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.